Research output per year
Research output per year
Personal profile
Research interests
Clinical trial development with a focus on advanced prostate cancer and bladder cancer; incorporating precision medicine into clinical trial design
Clinical interests
Prostate cancer, bladder cancer, kidney cancer, chemotherapy, immunotherapy
Fingerprint
Dive into the research topics where Melissa Reimers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma (Nature Communications, (2023), 14, 1, (1681), 10.1038/s41467-023-37211-7)
Wu, Y., Terekhanova, N. V., Caravan, W., Naser Al Deen, N., Lal, P., Chen, S., Mo, C. K., Cao, S., Li, Y., Karpova, A., Liu, R., Zhao, Y., Shinkle, A., Strunilin, I., Weimholt, C., Sato, K., Yao, L., Serasanambati, M., Yang, X., Wyczalkowski, M., & 22 others, Dec 2023, In: Nature communications. 14, 1, 2817.Research output: Contribution to journal › Comment/debate
Open Access -
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases (Prostate Cancer and Prostatic Diseases, (2022), 10.1038/s41391-022-00588-5)
Schoen, M. W., Carson, K. R., Eisen, S. A., Bennett, C. L., Luo, S., Reimers, M. A., Knoche, E. M., Whitmer, A. L., Yan, Y., Drake, B. F. & Sanfilippo, K. M., 2023, (Accepted/In press) In: Prostate Cancer and Prostatic Diseases.Research output: Contribution to journal › Comment/debate
Open Access -
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma
Wu, Y., Terekhanova, N. V., Caravan, W., Naser Al Deen, N., Lal, P., Chen, S., Mo, C. K., Cao, S., Li, Y., Karpova, A., Liu, R., Zhao, Y., Shinkle, A., Strunilin, I., Weimholt, C., Sato, K., Yao, L., Serasanambati, M., Yang, X., Wyczalkowski, M., & 22 others, Dec 2023, In: Nature communications. 14, 1, 1681.Research output: Contribution to journal › Article › peer-review
Open Access -
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Clinical Proteomic Tumor Analysis Consortium, Li, Y., Wu, Y., Lu, R. J. H., Chen, S., Zhao, Y., Caravan, W., Calinawan, A., Wyczalkowski, M. A., Wendl, M. C., Reimers, M. A., Pachynski, R., Van Tine, B. A., Chen, F., Ding, L. & Hsieh, J., Jan 9 2023, In: Cancer Cell. 41, 1, p. 139-163.e17Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients
Chauhan, P. S., Shiang, A., Alahi, I., Sundby, R. T., Feng, W., Gungoren, B., Nawaf, C., Chen, K., Babbra, R. K., Harris, P. K., Qaium, F., Hatscher, C., Antiporda, A., Brunt, L., Mayer, L. R., Shern, J. F., Baumann, B. C., Kim, E. H., Reimers, M. A., Smith, Z. L., & 1 others, Dec 2023, In: npj Precision Oncology. 7, 1, 6.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations